A Study of Decreased Mental Function Associated With HIV

Completed · Not applicable

Conditions studied: Cognitive Disorders, HIV Infections

In brief

The purpose of this study is to compare pictures of the brain of HIV-infected people with memory problems before and after treatment with selegiline. Selegiline is the study drug received through A5090. HIV patients generally develop memory problems late in the disease. This will be examined using noninvasive proton magnetic resonance spectroscopy (1H-MRS). The effect of the drug selegiline on memory problems also will be examined.

Key facts

Study ID
NCT00027040
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
90
Expected to finish
2005-06-01
Last updated by the study team
2015-01-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.